Between 2005 and 2015, nearly three-fourths of issued drug patents were for already existing drugs. A common argument in ...

The future of American drug innovation is threatened by U.S. regulations that permit knockoff versions of new drugs to be ...

On March 13, 2025, the U.S. Court of Appeals for the Federal Circuit affirmed a five-year patent term extension (“PTE”) for ...

The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...

The Federal Circuit’s refusal to reconsider its ruling forcing Teva to delist asthma-inhaler patents from the FDA’s Orange ...

Pharmaceutical company Novartis is laying off more than 400 employees at its East Hanover facility as part of a restructuring ...

On March 13, 2025, the Federal Circuit decided in Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc. (No. 2023-2254) how ...

UnitedHealth Group Inc.’s drug-benefits unit is starting to reimburse pharmacies more for dispensing brand-name medicines to ...

The Danish drugmaker had said it aims to launch its blockbuster weight-loss drug, Wegovy, in India by 2026. The active ...

Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover ...

The company has asked the U.S. patent office to reconsider patents that could prevent it from selling an update to Keytruda.

SaveHealth reports on the third-party companies that work to negotiate discounts with pharmacies and pharmacy benefit ...